4sc Ag

Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

Thomas Bär

Thomas Beckers

Thomas Maier

Astrid Zimmermann

Volker Gekeler

Mathias Schmidt

Klaus Pekari

Swen Hölder

Armin Zülch

Sarvesh S Patel

Rolf-Peter Hummel

Petra Gimmnich

Hemant Joshi

Martin Feth

Matthias Müller

Björn Bartels

Sachin Shivatare

Vikas Gore

Yogesh Munot

Siegfried Schneider

Umesh Bhise

Sunil Chavan

Ulf Bömer

Hartmut Rehwinkel

Ningshu Liu

Stuart Ince

Matthias Vennemann

Jürgen Volz

Frank Dullweber

Gerrit Beneke

Florian Dehmel

Jürgen Braunger

Uday Joshi

Dipak Harel

Andreas Strub

Mahindra Makhija

Matthias MÜLLER

Ulf BÖMER

Barbara Beckers

Kamlesh J Padiya

Sarvesh A Patel

Yogesh S Munot

Sachin S Shivatare

Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.

Fused bicyclic imidazoles

Fused pyrimidines

Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors. 

N-sulphonylpyrroles and their use as histone deacetylase inhibitors

Compounds of a certain formula I, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.

Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles

Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors

Compounds of a certain formula (I) in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and apoptosis inducing activity.

Tetrahydropyridothiophenes

Compounds of a certain formula (I), in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and apoptosis inducing activity.

Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer

Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer

Compounds of a certain formula (I) in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors.

Growing community of inventors

Reichenau, Germany

Thomas Bär